THE INFLUENCE OF INFLIXIMAB THERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS
Introduction. There is evidence that patients with ankylosing spondylitis (AS) in the early stages of the disease have a significantly decreased bone mass. However, the prevalence of osteoporosis, and the mechanism of its development in the AS are poorly understood. The appearance of inhibitors of t...
Main Authors: | T A Raskina, O A Pirogova |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2013-12-01
|
Series: | Остеопороз и остеопатии |
Subjects: | |
Online Access: | https://endojournals.ru/index.php/osteo/article/view/8862 |
Similar Items
-
INVESTIGATION OF A ROLE OF THE IMMUNOGENICITY OF INFLIXIMAB IN THE THERAPY OF ANKYLOSING SPONDYLITIS
by: O. A. Rumyantseva, et al.
Published: (2016-09-01) -
IZMENENIYa MINERAL'NOY PLOTNOSTI KOSTNOY TKANI U BOL'NYKh ANKILOZIRUYuShchIM SPONDILOARTRITOM
by: L. I. MYaSOUTOVA, et al.
Published: (2011-12-01) -
Роль препаратов кальция в комплексном лечении постменопаузального остеопороза
Published: (2016-12-01) -
Interrelation of bone mineral density with kneeosteoarthrosis
by: E. M. Zaytseva, et al.
Published: (2011-04-01) -
Assessment of bone tissue architectonics with digital analysis of computed tomograms for osteoporosis diagnostics
by: O. Yu. Kilina, et al.
Published: (2003-06-01)